Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:N Engl J Med
Asıl Yazarlar: Walsh, Edward E., Frenck, Robert W., Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J., Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R., Jansen, Kathrin U., Şahin, Uğur, Gruber, William C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Massachusetts Medical Society 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://ncbi.nlm.nih.gov/pubmed/33053279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2027906
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller